Guocai H. Wu

Zhanjiang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Highly suppressive functional CCR7 low Treg subset cells may correlate with poor prognosis of B-ALL.

Highly suppressive functional CCR7 low Treg subset cells may correlate with poor prognosis of B-ALL.

Journal: Hematology (Amsterdam, Netherlands)
Published: July 28, 2026

TRMT6/61A-mediated tRNA m1A methylation promotes codon-dependent TAB2 translation and drives AML progression.

TRMT6/61A-mediated tRNA m1A methylation promotes codon-dependent TAB2 translation and drives AML progression.

Journal: Molecular medicine (Cambridge, Mass.)
Published: February 09, 2026

DOCK1 inhibitor Box5 (TFA) suppresses proliferation of AML cell lines and prolongs survival in AML xenograft models.

DOCK1 inhibitor Box5 (TFA) suppresses proliferation of AML cell lines and prolongs survival in AML xenograft models.

Journal: Scientific reports
Published: February 06, 2026

Integrative Analysis of Genetic Risk Factors for Acute Myeloid Leukemia Using Mendelian Randomization and Single-Cell RNA Sequencing Validation.

Integrative Analysis of Genetic Risk Factors for Acute Myeloid Leukemia Using Mendelian Randomization and Single-Cell RNA Sequencing Validation.

Journal: International journal of genomics
Published: January 09, 2026

Healthy birth after chemotherapy for diffuse large B-cell lymphoma with superior vena cava syndrome in late pregnancy: A case report.

Healthy birth after chemotherapy for diffuse large B-cell lymphoma with superior vena cava syndrome in late pregnancy: A case report.

Journal: SAGE open medical case reports
Published: December 01, 2025

Efficacy and safety of OB756 (a novel selective JAK2 inhibitor) for essential thrombocythemia in patients intolerant of or resistant to hydroxyurea or intolerant of interferon: A phase 2, open-label, multicenter study.

Efficacy and safety of OB756 (a novel selective JAK2 inhibitor) for essential thrombocythemia in patients intolerant of or resistant to hydroxyurea or intolerant of interferon: A phase 2, open-label, multicenter study.

Journal: Cancer
Published: July 14, 2025

Identification and validation of three tumor suppressors associated with the immune response of acute myeloid leukemia.

Identification and validation of three tumor suppressors associated with the immune response of acute myeloid leukemia.

Journal: Frontiers in genetics
Published: June 23, 2025

The m5C methyltransferase NSUN2 promotes progression of acute myeloid leukemia by regulating serine metabolism.

The m5C methyltransferase NSUN2 promotes progression of acute myeloid leukemia by regulating serine metabolism.

Journal: Cell reports
Published: October 07, 2024

Validation for the function of protein C in mouse models.

Validation for the function of protein C in mouse models.

Journal: PeerJ
Published: November 13, 2023

Identification and validation of a prognostic risk-scoring model for AML based on m7G-associated gene clustering.

Identification and validation of a prognostic risk-scoring model for AML based on m7G-associated gene clustering.

Journal: Frontiers in oncology
Published: September 24, 2023

An office building outbreak: the changing epidemiology of tuberculosis in Shenzhen, China.

An office building outbreak: the changing epidemiology of tuberculosis in Shenzhen, China.

Journal: Epidemiology and infection
Published: February 25, 2020
Showing 1-11 of 11

Last Updated: 09/26/2026